ACHE and Alzheimer disease: Aging and AD are associated with deficits of ACh due to hydrolysis by acetyl choline esterase at the synaptic site of the brain, therefore, targeting AChE activity is a potential therapeutic approach for memory-enhancing research or AD [18,19].